The car factory is a big employer in the area. Can you believe the mags. Can you believe the magazine sells seven thousands copies a month. A lawyer has been hired to handle the case. Do you know how much the house is worth. Don't hesitate anymore. The best time to invest is now....
This article reviews the book "Big Pharma: How the World's Biggest Drug Companies Control Illness," by Jacky Law. Grant,Ian,F. - 《New Zealand Management》 被引量: 41发表: 2006年 Why is Big Pharma Getting out of Antibacterial Drug Discovery? Since the advent of the antibiotic era in th...
while luxury homes abound (充裕), and homelessness remains a persistent problem. Despite this, popular culture and the housing industry market happiness as living with both more space and more amenities (便利设施). Big house...
43、I like to think ___. I am always the one finding new ways to a situation or challenge. 44、I think a big part of it is ___ we know how to have fun on the job. 45、I think the primary ___factor is there's been so much absence lately. 46、I would recommend...
the pharmaceutical industry when he realized over-the-top marketing of drugs was at odds with his patients’ interests. He wrote Overdosing America, and became an expert witness in a landmark class action lawsuit over the now-withdrawn drug Bextra. His new book, "Sickening: How Big Pharma ...
Big Pharma - How much power do drug companies have的剧情简介 ··· The pharmaceutical industry exerts a huge amount of influence on health policy. Some companies develop highly profitable drugs with public money, while others have been found to have covered up serious side effects. The fight...
India's pharmaceutical industry: hype or high tech take-off? Key elements of the present shake-up include the return of 'big pharma' companies on a large scale and the emergence of several Indian firms that aim... Prabodh,Malhotra,Hans,... - 《Australian Health Review A Publication of th...
their growth objective if they rely too heavily on their internal R&D alone. Taking an ecosystem approach that fosters alliances and M&A with companies producing early-stage products, digital investing and technology can help close the innovation gap that big biopharmas might face in the coming ...
After years of litigation and a $50 billion settlement, big pharma is rushing to develop non-addictive pain treatments. Jennison's Debra Netschert and MarketWatch's Eleanor Laise explain how non-addictive drugs could revolutionize the industry....